孕二烯酮
孕二烯酮结构式
|
常用名 | 孕二烯酮 | 英文名 | Gestodene |
|---|---|---|---|---|
| CAS号 | 60282-87-3 | 分子量 | 310.430 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 462.7±45.0 °C at 760 mmHg | |
| 分子式 | C21H26O2 | 熔点 | 190-192°C | |
| MSDS | 中文版 美版 | 闪点 | 196.9±21.3 °C | |
| 符号 |
GHS08 |
信号词 | Warning |
|
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Obstet. Gynecol. Clin. North Am. 21(2) , 299-319, (1994) Clofarabine was the latest new drug to be approved, in 2004, for relapsed or refractory acute lymphoblastic leukaemia (ALL). To investigate its value in the frontline treatment of ALL we applied clofarabine 5 × 40 mg/m(2) in combination with pegylated asparag... |
|
|
Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.
Gynecol. Endocrinol. 26(4) , 265-9, (2010) The objective of the present study was to determine whether there is an increase in endometrial inflammation associated with the occurrence of breakthrough bleeding in patients using an oral contraceptive in extended regimens. The presence of nuclear factor N... |
|
|
17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.
Gynecol. Endocrinol. 28(8) , 606-10, (2012) We studied (1) the effects of oral contraceptive pills (OCPs) on hirsutism, hormonal and metabolic variables in 49 polycystic ovary syndrome patients without metabolic comorbidities and (2) the effect of 17-hydroxysteroid dehydrogenase type 5 gene polymorphis... |
|
|
Phase of oral contraceptive cycle and endurance capacity of rowers.
Percept. Mot. Skills 113(3) , 764-72, (2011) Eight female rowers (M age = 21.0 yr., SD = 2.8), using a monophasic oral-contraceptive pill, performed a 1-hr. rowing ergometer test (intensity: 70% VO2max) during the active-pill and non active-pill phases of the oral contraceptive cycle. No significant dif... |
|
|
Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
J. Fam. Plann. Reprod. Health Care 38(1) , 2-6, (2012)
|
|
|
Risk of blood clots higher for oral contraceptives with certain progestins.
JAMA 306(20) , 2206, (2011)
|
|
|
Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.
Am. J. Obstet. Gynecol. 160(5 Pt 2) , 1296-300, (1989) Three new 19-nortestosterone progestogens, which are chemically related to levonorgestrel, are now clinically available in combination oral contraceptives in Europe. Desogestrel and norgestimate must be transformed to metabolites for all or part of their biol... |
|
|
Influence of third-generation oral contraceptives on the complexity analysis and symbolic dynamics of heart rate variability.
Eur. J. Contracept. Reprod. Health Care 16(4) , 289-97, (2011) To evaluate the influence of oral contraceptives (OCs) containing 20 μg ethinylestradiol (EE) and 150 μg gestodene (GEST) on the autonomic modulation of heart rate (HR) in women.One-hundred and fifty-five women aged 24 ± 2 years were divided into four groups ... |
|
|
Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo
Eur. J. Obstet. Gynecol. Reprod. Biol. 147(1) , 72-7, (2009) Objective(s) To assess the recurrence rate of endometrioma after laparoscopic cystectomy plus hormonal suppression treatment or plus dietary therapy compared to post-operative placebo. |
|
|
New progestins--clinical experiences: gestodene.
Am. J. Obstet. Gynecol. 170(5 Pt 2) , 1562-8, (1994) Gestodene, one of three new gonane progestins, is the most potent on a per weight basis in regard to progestational effects and has little or no estrogenic effect. In in vivo animal studies, gestodene also has less androgenic activity compared with progestins... |